Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
859.00    8.00 (0.94%)
Bid:
884.00
Ask:
793.00
Spread: -91.00 (-10.294%)
Market Cap: £1.19b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Director/PDMR Shareholding

28 Apr 2020 15:53

RNS Number : 2105L
Savills PLC
28 April 2020
 

SAVILLS PLC (THE 'COMPANY')

NOTIFICATION OF INTERESTS OF DIRECTORS/ PERSONS DISCHARGING MANAGERIAL RESPONSIBILIES ('PDMRS')

 

Vesting and Grant of Share Awards

 

Awards made on 18 April 2017 over ordinary shares of the Company under the Company's Deferred Share Plans have now become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustee of The Savills plc 1992 Employee Benefit Trust ('Trustee') effected the transfer of shares, following the settlement of associated tax liabilities through the sale of shares which completed on 27 April 2020, to Directors and PDMRS of the Company as detailed in the table below.

 

The Company also announces that on 27 April 2020 the grant of the share based element of 2019 profit share awards was made under the Savills Deferred Share Bonus Plan to Directors and PDMRS of the Company as detailed in the table below.

 

Director / PDMR

Number of Shares Transferred to Director / PDMR by Trustee

Number of Shares sold by Trustee to settle associated tax liabilities

Director / PDMR Shareholding following this notification

Shareholding as a % of issued share capital

Number of Shares subject to the Savills Deferred Share Bonus Plan awarded to the Director / PDMR

Beneficial interest under the Deferred Share Plans following this notification

Mark Ridley (Director)

27,360

24,357

210,321

0.15%

85,446

171,611

Simon Shaw (Director)

26,715

23,783

182,579

0.13%

63,821

175,537

Simon Hope (PDMR)

3,693

3,271

190,789

0.13%

5,652

18,781

Chris Lee (PDMR)

7,122

6,343

112,138

0.08%

13,329

37,851

Christian Mancini (PDMR)

8,183

n/a

112,407

0.08%

7,974

26,789

Mitchell Rudin (PDMR)

n/a

n/a

34,158

0.02%

12,811

184,756

James Sparrow (PDMR)

n/a

n/a

58,798

0.04%

35,681

69,140

Mitchell Steir (PDMR)

5,187

5,644

52,500

0.04%

21,488

46,033

 

The share price on disposal of shares to settle associated tax liabilities was £8.823376 per share.

All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the person discharging managerial responsibilities/ person closely associated

 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Simon Hope

4. Chris Lee

5. Christian Mancini

6. Mitchell Rudin

7. James Sparrow

8. Mitchell Steir

 

2.

Reason for the notification

 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Global Head of Capital Markets/ PDMR

4. Group Legal Director and Company Secretary/ PDMR

5. Chief Executive Officer Asia Pacific (ex-Greater China) / PDMR

6. President, Savills US / PDMR

7. Chief Executive Officer UK & EMEA/ PDMR

8. Chairman and CEO - Savills North America/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Vesting of awards under the Company's Deferred Share Plans and sale of shares to settle associated tax liabilities

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

Number of Shares Transferred at nil cost by Trustee to Director / PDMR

 

1. 27,360

2. 26,715

3. 3,693

4. 7,122

5. 8,183

6. n/a

7. n/a

8. 5,187

 

Number of Shares sold by Trustee to settle tax liabilities at £8.823376 per share

 

1. 24,357

2. 23,783

3. 3,271

4. 6,343

5. n/a

6. n/a

7. n/a

8. 5,644

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

27 April 2020

(g)

Place of the transaction

 

Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan ('DSBP')

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£nil per share

 

1. 85,446

2. 63,821

3. 5,652

4. 13,329

5. 7,974

6. 12,811

7. 35,681

8. 21,488

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

27 April 2020

(g)

Place of the transaction

 

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

28 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKZGZDDRGGGZM
Date   Source Headline
2nd Jan 20253:00 pmRNSTotal Voting Rights
16th Dec 20244:03 pmRNSHolding(s) in Company
12th Dec 202411:00 amRNSDirector/PDMR Shareholding
2nd Dec 202410:00 amRNSTotal Voting Rights
26th Nov 20243:34 pmRNSHolding(s) in Company
22nd Nov 20242:00 pmRNSAdditional Listing
15th Nov 20242:58 pmRNSHolding(s) in Company
14th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20241:47 pmRNSHolding(s) in Company
12th Nov 20242:51 pmRNSDirector/PDMR Shareholding
12th Nov 20242:48 pmRNSHolding(s) in Company
11th Nov 20242:25 pmRNSHolding(s) in Company
1st Nov 202411:00 amRNSTotal Voting Rights
14th Oct 20249:52 amRNSDirector/PDMR Shareholding
4th Oct 20242:00 pmRNSAdditional Listing
1st Oct 202411:00 amRNSTotal Voting Rights
18th Sep 20242:43 pmRNSDirector Declaration
16th Sep 20243:50 pmRNSDirector Declaration
12th Sep 20241:47 pmRNSDirector/PDMR Shareholding
2nd Sep 202411:00 amRNSTotal Voting Rights
29th Aug 20242:24 pmRNSDirector/PDMR Shareholding
15th Aug 202411:00 amRNSBlock listing Interim Review
13th Aug 20243:17 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSHalf-year Report
1st Aug 202411:00 amRNSTotal Voting Rights
30th Jul 20242:11 pmRNSHolding(s) in Company
22nd Jul 20242:36 pmRNSBlock listing Interim Review
11th Jul 20244:26 pmRNSDirector/PDMR Shareholding
1st Jul 20249:27 amRNSTotal Voting Rights
20th Jun 202410:36 amRNSDirector/PDMR Shareholding
13th Jun 20241:37 pmRNSDirector/PDMR Shareholding
11th Jun 20244:42 pmRNSDirector/PDMR Shareholding
7th Jun 20244:01 pmRNSDirector/PDMR Shareholding
4th Jun 20242:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202411:00 amRNSTotal Voting Rights
23rd May 20242:21 pmRNSDirector/PDMR Shareholding
17th May 20243:44 pmRNSDirector/PDMR Shareholding
15th May 20243:06 pmRNSResult of AGM
15th May 202410:02 amRNSAGM Statement
14th May 20248:00 amRNSDirector/PDMR Shareholding
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.